BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 14770437)

  • 1. Neurologic disorders in 432 consecutive patients with small cell lung carcinoma.
    Seute T; Leffers P; ten Velde GP; Twijnstra A
    Cancer; 2004 Feb; 100(4):801-6. PubMed ID: 14770437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurologic disorders in 203 consecutive patients with small cell lung cancer. Results of a longitudinal study.
    van Oosterhout AG; van de Pol M; ten Velde GP; Twijnstra A
    Cancer; 1996 Apr; 77(8):1434-41. PubMed ID: 8608526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurologic disorders in patients with small cell lung cancer.
    Sculier JP; Feld R; Evans WK; DeBoer G; Shepherd FA; Payne DG; Pringle JF; Yeoh JL; Quirt IC; Curtis JE
    Cancer; 1987 Nov; 60(9):2275-83. PubMed ID: 2830955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptomeningeal metastases from small cell lung carcinoma.
    Seute T; Leffers P; ten Velde GP; Twijnstra A
    Cancer; 2005 Oct; 104(8):1700-5. PubMed ID: 16080173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension and risk of brain metastasis from small cell lung cancer: a retrospective follow-up study.
    Sahmoun AE; Case LD; Chavour S; Kareem S; Schwartz GG
    Anticancer Res; 2004; 24(5B):3115-20. PubMed ID: 15510598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI).
    Seute T; Leffers P; ten Velde GP; Twijnstra A
    Cancer; 2008 Apr; 112(8):1827-34. PubMed ID: 18311784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis.
    Hochstenbag MM; Twijnstra A; Wilmink JT; Wouters EF; ten Velde GP
    J Neurooncol; 2000 Jul; 48(3):243-8. PubMed ID: 11100822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non-small cell lung cancer brain metastases.
    Steindl A; Yadavalli S; Gruber KA; Seiwald M; Gatterbauer B; Dieckmann K; Frischer JM; Klikovits T; Zöchbauer-Müller S; Grisold A; Hoda MAR; Marosi C; Widhalm G; Preusser M; Berghoff AS
    Cancer; 2020 Oct; 126(19):4341-4352. PubMed ID: 32678971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) in patients with limited stage small cell lung cancer.
    Tai P; Yu E; Jones K; Sadikov E; Mahmood S; Tonita J
    Lung Cancer; 2006 Aug; 53(2):211-5. PubMed ID: 16787684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and prognostic factors in single brain metastases from small-cell lung cancer.
    Bernhardt D; Adeberg S; Bozorgmehr F; Opfermann N; Hörner-Rieber J; König L; Kappes J; Thomas M; Unterberg A; Herth F; Heußel CP; Warth A; Debus J; Steins M; Rieken S
    Strahlenther Onkol; 2018 Feb; 194(2):98-106. PubMed ID: 29085978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data.
    Goncalves PH; Peterson SL; Vigneau FD; Shore RD; Quarshie WO; Islam K; Schwartz AG; Wozniak AJ; Gadgeel SM
    Cancer; 2016 Jun; 122(12):1921-7. PubMed ID: 27062154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of asymptomatic brain metastases from small-cell lung cancer to systemic first-line chemotherapy.
    Seute T; Leffers P; Wilmink JT; ten Velde GP; Twijnstra A
    J Clin Oncol; 2006 May; 24(13):2079-83. PubMed ID: 16648509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syndrome of Inappropriate Antidiuretic Hormone Secretion: A Poor Prognosis in Small-cell Lung Cancer.
    Wang X; Liu M; Zhang L; Ma K
    Arch Med Res; 2016 Jan; 47(1):19-24. PubMed ID: 26706100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inappropriate antidiuretic hormone secretion disclosing a second primary lung cancer 5 years after complete remission of a small cell lung carcinoma].
    Soria JC; Fizazi K; Merad M; Le Chevalier T
    Bull Cancer; 1996 Aug; 83(8):605-8. PubMed ID: 8869039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic cranial irradiation in limited-stage small-cell lung cancer: a retrospective analysis.
    Alshehadat S; Sahmoun AE
    Clin Adv Hematol Oncol; 2004 Jun; 2(6):397-400. PubMed ID: 16163213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Present role of prophylactic cranial irradiation].
    Le Péchoux C; Al Mohkles H; Dhermain F
    Bull Cancer; 2013 Jan; 100(1):35-43. PubMed ID: 23306141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndrome of inappropriate ADH secretion and diplopia: oat cell (small cell) rectal carcinoma metastatic to the central nervous system.
    Khansur TK; Routh A; Mihas TA; Underwood JA; Smith GF; Mihas AA
    Am J Gastroenterol; 1995 Jul; 90(7):1173-4. PubMed ID: 7611224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yield of workup for patients with idiopathic presentation of the syndrome of inappropriate antidiuretic hormone secretion.
    Shepshelovich D; Leibovitch C; Klein A; Zoldan S; Shochat T; Green H; Rozen-Zvi B; Lahav M; Gafter-Gvili A
    Eur J Intern Med; 2016 Jul; 32():60-4. PubMed ID: 27016871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic syndromes associated with small cell lung cancer.
    Marchioli CC; Graziano SL
    Chest Surg Clin N Am; 1997 Feb; 7(1):65-80. PubMed ID: 9001756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
    Fetscher S; Brugger W; Engelhardt R; Kanz L; Hasse J; Frommhold H; Wenger M; Lange W; Mertelsmann R
    Ann Oncol; 1997 Jan; 8(1):49-56. PubMed ID: 9093707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.